Farris Karen B, Carter Barry L, Xu Yinghui, Dawson Jeffrey D, Shelsky Constance, Weetman David B, Kaboli Peter J, James Paul A, Christensen Alan J, Brooks John M
College of Pharmacy, University of Michigan, 428 Church St, Ann Arbor MI 48109-1065, USA.
BMC Health Serv Res. 2014 Sep 18;14:406. doi: 10.1186/1472-6963-14-406.
Pharmacists may improve medication-related outcomes during transitions of care. The aim of the Iowa Continuity of Care Study was to determine if a pharmacist case manager (PCM) providing a faxed discharge medication care plan from a tertiary care institution to primary care could improve medication appropriateness and reduce adverse events, rehospitalization and emergency department visits.
Design. Randomized, controlled trial of 945 participants assigned to enhanced, minimal and usual care groups conducted 2007 to 2012. Subjects. Participants with cardiovascular-related conditions and/or asthma or chronic obstructive pulmonary disease were recruited from the University of Iowa Hospital and Clinics following admission to general medicine, family medicine, cardiology or orthopedics. Intervention. The minimal group received admission history, medication reconciliation, patient education, discharge medication list and medication recommendations to inpatient team. The enhanced group also received a faxed medication care plan to their community physician and pharmacy and telephone call 3-5 days post-discharge. Participants were followed for 90 days post-discharge. Main Outcomes and Measures. Medication appropriateness index (MAI), adverse events, adverse drug events and post-discharge healthcare utilization were compared by study group using linear and logistic regression, as models accommodating random effects due to pharmacists indicated little clustering.
Study groups were similar at baseline and the intervention fidelity was high. There were no statistically significant differences by study group in medication appropriateness, adverse events or adverse drug events at discharge, 30-day and 90-day post-discharge. The average MAI per medication as 0.53 at discharge and increased to 0.75 at 90 days, and this was true across all study groups. Post-discharge, about 16% of all participants experienced an adverse event, and this did not differ by study group (p > 0.05). Almost one-third of all participants had any type of healthcare utilization within 30 days post-discharge, where 15% of all participants had a 30-day readmission. Healthcare utilization post-discharge was not statistically significant different at 30 or 90 days by study group.
The pharmacist case manager did not affect medication use outcomes post-discharge perhaps because quality of care measures were high in all study groups.
Clinicaltrials.gov registration: NCT00513903, August 7, 2007.
药剂师可以在医疗护理转接期间改善与用药相关的结果。爱荷华州医疗护理连续性研究的目的是确定药剂师病例管理员(PCM)从三级医疗机构向初级护理机构提供一份传真的出院用药护理计划是否能够提高用药合理性,并减少不良事件、再次住院和急诊就诊次数。
设计。2007年至2012年对945名参与者进行随机对照试验,将其分为强化护理组、最低护理组和常规护理组。受试者。患有心血管相关疾病和/或哮喘或慢性阻塞性肺疾病的参与者在入住爱荷华大学医院和诊所的普通内科、家庭医学、心脏病学或骨科后被招募。干预措施。最低护理组接受入院病史、用药核对、患者教育、出院用药清单以及给住院团队的用药建议。强化护理组还会收到一份传真给其社区医生和药房的用药护理计划,以及出院后3 - 5天的电话随访。参与者出院后随访90天。主要结局和测量指标。使用线性和逻辑回归按研究组比较用药合理性指数(MAI)、不良事件、药物不良事件和出院后医疗保健利用率,因为考虑到药剂师因素的随机效应模型显示聚类很少。
各研究组在基线时相似,干预依从性高。在出院时、出院后30天和90天,各研究组在用药合理性、不良事件或药物不良事件方面无统计学显著差异。每种药物的平均MAI出院时为0.53,90天时增至0.75,所有研究组均如此。出院后,约16%的所有参与者经历了不良事件,各研究组之间无差异(p>0.05)。几乎三分之一的所有参与者在出院后30天内有任何类型的医疗保健利用,其中15%的所有参与者在30天内再次入院。各研究组在出院后30天或90天的医疗保健利用率无统计学显著差异。
药剂师病例管理员对出院后的用药结果没有影响,可能是因为所有研究组的护理质量措施都很高。
Clinicaltrials.gov注册:NCT00513903,2007年8月7日。